NPT-1220312

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameNPT-1220312

Drug Alias NameTLR2 inhibitors (Neuropore Therapies)TLR2 modulators (Neuropore Therapies)TLR2 modulators (Neuropore Therapies)TLR2 antagonist (Neuropore Therapies)NPT-1220312

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionToll like receptor 2 inhibitors

TargetsToll like receptor 2

Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral SclerosisParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNeuropore Therapies Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNeuropore Therapies Inc

Active IndicationsN/A

Inactive IndicationsNerve DegenerationAmyotrophic Lateral SclerosisParkinson Disease

Other Information

ATC CodeN/A